These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 12436484

  • 1. Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain.
    Liang M, Mahler M, Koch J, Ji Y, Li D, Schmaljohn C, Bautz EK.
    J Med Virol; 2003 Jan; 69(1):99-107. PubMed ID: 12436484
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Analysis of immune responses against nucleocapsid protein of the Hantaan virus elicited by virus infection or DNA vaccination.
    Woo GJ, Chun EY, Kim KH, Kim W.
    J Microbiol; 2005 Dec; 43(6):537-45. PubMed ID: 16410771
    [Abstract] [Full Text] [Related]

  • 4. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.
    Hooper JW, Custer DM, Thompson E, Schmaljohn CS.
    J Virol; 2001 Sep; 75(18):8469-77. PubMed ID: 11507192
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Hantaan and Seoul viral infections among patients with hemorrhagic fever with renal syndrome (HFRS) in Heilongjiang, China.
    Zhang X, Chen HY, Zhu LY, Zeng LL, Wang F, Li QG, Shao FJ, Jiang HQ, Liu SJ, Ma YJ, Zhu Y, Ma YJ.
    Scand J Infect Dis; 2011 Aug; 43(8):632-41. PubMed ID: 21428852
    [Abstract] [Full Text] [Related]

  • 6. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R, Bugli F, Mancini N, Rosa D, Di Campli C, Moroncini G, Manzin A, Abrignani S, Varaldo PE, Clementi M, Fadda G.
    Virology; 2001 Sep 15; 288(1):29-35. PubMed ID: 11543655
    [Abstract] [Full Text] [Related]

  • 7. Development and evaluation of serological assays for detection of Hantaanvirus-specific antibodies in human sera using yeast-expressed nucleocapsid protein.
    Petraityte R, Yang H, Hunjan R, Razanskiene A, Dhanilall P, Ulrich RG, Sasnauskas K, Jin L.
    J Virol Methods; 2008 Mar 15; 148(1-2):89-95. PubMed ID: 18077007
    [Abstract] [Full Text] [Related]

  • 8. Epitope mapping studies with neutralizing and non-neutralizing monoclonal antibodies to the G1 and G2 envelope glycoproteins of Hantaan virus.
    Wang M, Pennock DG, Spik KW, Schmaljohn CS.
    Virology; 1993 Dec 15; 197(2):757-66. PubMed ID: 7504368
    [Abstract] [Full Text] [Related]

  • 9. [Identification of HTNV-NP-specific T lymphocyte epitopes and analysis of the epitope-specific T cell response].
    Wang ML, Zhu Y, Wang JP, Liu JM, Fang L, Jin BQ.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Nov 15; 21(6):704-6. PubMed ID: 16256031
    [Abstract] [Full Text] [Related]

  • 10. Cellular immune response to Hantaan virus nucleocapsid protein in the acute phase of hemorrhagic fever with renal syndrome: correlation with disease severity.
    Wang M, Wang J, Zhu Y, Xu Z, Yang K, Yang A, Jin B.
    J Infect Dis; 2009 Jan 15; 199(2):188-95. PubMed ID: 19072554
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Isolation of therapeutic human monoclonal antibodies for varicella-zoster virus and the effect of light chains on the neutralizing activity.
    Suzuki K, Akahori Y, Asano Y, Kurosawa Y, Shiraki K.
    J Med Virol; 2007 Jun 15; 79(6):852-62. PubMed ID: 17457901
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A soluble and heat-resistant form of hantavirus nucleocapsid protein for the serodiagnosis of HFRS.
    Park SM, Kim J.
    J Virol Methods; 2008 Jan 15; 147(1):1-9. PubMed ID: 17826847
    [Abstract] [Full Text] [Related]

  • 15. Characterization of truncated hantavirus nucleocapsid proteins and their application for serotyping.
    Li G, Pan L, Mou D, Chen Y, Zhang Y, Li X, Ren J, Wang P, Zhang Y, Jia Z, Huang C, Sun Y, Yang W, Xiao SY, Bai X.
    J Med Virol; 2006 Jul 15; 78(7):926-32. PubMed ID: 16721853
    [Abstract] [Full Text] [Related]

  • 16. Antigenic characterization of expressed complete and different truncated recombinant nucleocapsid proteins of hantaan virus by monoclonal antibodies.
    Lü X, Zhang F, Li Y, Xue X, Yin W, Xu Z.
    Hybridoma (Larchmt); 2011 Oct 15; 30(5):445-50. PubMed ID: 22008071
    [Abstract] [Full Text] [Related]

  • 17. Human recombinant neutralizing antibodies against hantaan virus G2 protein.
    Koch J, Liang M, Queitsch I, Kraus AA, Bautz EK.
    Virology; 2003 Mar 30; 308(1):64-73. PubMed ID: 12706090
    [Abstract] [Full Text] [Related]

  • 18. Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.
    Goncalvez AP, Men R, Wernly C, Purcell RH, Lai CJ.
    J Virol; 2004 Dec 30; 78(23):12910-8. PubMed ID: 15542643
    [Abstract] [Full Text] [Related]

  • 19. Construction and characterization of a Fab recombinant protein for Japanese encephalitis virus neutralization.
    Wu SC, Lin YJ, Chou JW, Lin CW.
    Vaccine; 2004 Nov 25; 23(2):163-71. PubMed ID: 15531033
    [Abstract] [Full Text] [Related]

  • 20. Neutralizing human Fab fragments against measles virus recovered by phage display.
    de Carvalho Nicacio C, Williamson RA, Parren PW, Lundkvist A, Burton DR, Björling E.
    J Virol; 2002 Jan 25; 76(1):251-8. PubMed ID: 11739690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.